New Frontier in Fight Against Rare Disease
Date posted: November 1, 2021
Nancy Mendelsohn, MD, chief medical officer for Optum Frontier Therapies and senior vice president, medical affairs, genetics and rare disease for UnitedHealth Group, authored the article "A New Frontier in the Fight Against Rare Disease," featured in Pharmacy Times.
Compassionate service and support
The piece highlights the importance of providing higher levels of service and support to people living with rare disease. Also critical is the role of collaboration among pharmaceutical manufacturers, providers and payers.
As we look ahead, the industry will need to focus on building new benefit models for rare disease, improving access to genomic testing, and helping with affordability, among other priorities.
But above all, Mendelsohn writes, it is imperative that we support patients and their families with compassion while creating access to these innovative therapies.